Ipsen Biopharma

SOMATULINE DEPOT

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Ipsen Biopharma

Somatuline Depot HCPCS:

J1930

HCPCS Code Descriptor:

Injection, lanreotide, 1 mg

Category:

J Code

Somatuline Depot NDCs:

15054-1120-04, 15054-1060-04, 15054-1090-04

Primary Type:

Growth Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Somatuline Depot CPT Codes:

Potential CPT administration codes for Somatuline Depot can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Somatuline Depot:

SOMATULINE DEPOT is a Growth Disorder drug manufactured by Ipsen Biopharma and administered via the Subcutaneous route of administration. The J Code: J1930 is aligned to the drug SOMATULINE DEPOT.

ACCESS PRICING AND MORE BY REGISTERING

J1930 Added Date:

January 1, 2009

J1930 Effective Date:

January 1, 2009

J1930 Termination Date:

HCPCS Active

Somatuline Depot billing and coding information can be found through Ipsen Biopharma at the link below:
Somatuline Depot patient assistance information can be found through Ipsen Cares at the URL: https://www.somatulinedepot.com/en-us/support/patient-assistance
SOMATULINE DEPOT prescribing information can be found at the link below:
Information regarding SOMATULINE DEPOT’s side effects can be found at MedlinePlus